APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Corticosteroid

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ophthalmic Corticosteroid Industry Growth and Trends Forecast to 2032

28 December 2025114 pages

Choose your research edition.

Industry ResearchOphthalmic Corticosteroid Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Corticosteroid Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Ophthalmic Corticosteroid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Corticosteroid Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Corticosteroid Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

According to APO Research, the global Ophthalmic Corticosteroid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ophthalmic Corticosteroid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Corticosteroid is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Corticosteroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Ophthalmic Corticosteroid market include Novartis AG, Pfizer, GlaxoSmithKline, Bayer AG, Sun Pharmaceutical, Regeneron Pharmaceuticals, Orchidia, Innovative Pharmaceuticals and General Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ophthalmic Corticosteroid market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ophthalmic Corticosteroid market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ophthalmic Corticosteroid market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ophthalmic Corticosteroid.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Ophthalmic Corticosteroid market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ophthalmic Corticosteroid Market by Company

Novartis AG

Pfizer

GlaxoSmithKline

Bayer AG

Sun Pharmaceutical

Regeneron Pharmaceuticals

Orchidia

Innovative Pharmaceuticals

General Pharmaceuticals

Genentech

Bausch Health

Bausch and Lomb

Allergan

Alimera Sciences

Ajanta Pharma

Ophthalmic Corticosteroid Segment by Type

Dexamethasone

Difluprednate

Fluorometholone

Loteprednol

Others

Ophthalmic Corticosteroid Segment by Application

Hospital Pharmacies

Research Institute

Online Pharmacies

Retail Pharmacies

Others

Ophthalmic Corticosteroid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Corticosteroid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Corticosteroid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Corticosteroid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Ophthalmic Corticosteroid companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Ophthalmic Corticosteroid Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Ophthalmic Corticosteroid Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Ophthalmic Corticosteroid Market Share by Region (2021-2026) Table 4. Global Ophthalmic Corticosteroid Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Ophthalmic Corticosteroid Market Share by Region (2027-2032) Table 6. Global Ophthalmic Corticosteroid Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Ophthalmic Corticosteroid Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Ophthalmic Corticosteroid Market Size Share by Type (2021-2026) Table 9. Global Ophthalmic Corticosteroid Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Ophthalmic Corticosteroid Market Size Share Forecasted by Type (2027-2032) Table 11. North America Ophthalmic Corticosteroid Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Ophthalmic Corticosteroid Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Ophthalmic Corticosteroid Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Ophthalmic Corticosteroid Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Ophthalmic Corticosteroid Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Ophthalmic Corticosteroid Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Ophthalmic Corticosteroid Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Ophthalmic Corticosteroid Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Ophthalmic Corticosteroid Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Ophthalmic Corticosteroid Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Ophthalmic Corticosteroid Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Ophthalmic Corticosteroid Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Ophthalmic Corticosteroid Market Size Share by Application (2021-2026) Table 24. Global Ophthalmic Corticosteroid Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Ophthalmic Corticosteroid Market Size Share Forecasted by Application (2027-2032) Table 26. North America Ophthalmic Corticosteroid Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Ophthalmic Corticosteroid Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Ophthalmic Corticosteroid Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Ophthalmic Corticosteroid Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Ophthalmic Corticosteroid Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Ophthalmic Corticosteroid Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Ophthalmic Corticosteroid Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Ophthalmic Corticosteroid Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Ophthalmic Corticosteroid Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Ophthalmic Corticosteroid Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Ophthalmic Corticosteroid Industry Trends Table 37. Ophthalmic Corticosteroid Industry Drivers Table 38. Ophthalmic Corticosteroid Industry Opportunities and Challenges Table 39. Ophthalmic Corticosteroid Industry Restraints Table 40. Global Ophthalmic Corticosteroid Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Ophthalmic Corticosteroid Revenue Market Share by Company (2021-2026) Table 42. Global Ophthalmic Corticosteroid Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Ophthalmic Corticosteroid Key Company Headquarters & Area Served Table 44. Global Ophthalmic Corticosteroid Company, Product Type & Application Table 45. Global Ophthalmic Corticosteroid Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Ophthalmic Corticosteroid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Novartis AG Company Information Table 49. Novartis AG Business Overview Table 50. Novartis AG Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Novartis AG Ophthalmic Corticosteroid Product Portfolio Table 52. Novartis AG Recent Development Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Pfizer Ophthalmic Corticosteroid Product Portfolio Table 57. Pfizer Recent Development Table 58. GlaxoSmithKline Company Information Table 59. GlaxoSmithKline Business Overview Table 60. GlaxoSmithKline Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GlaxoSmithKline Ophthalmic Corticosteroid Product Portfolio Table 62. GlaxoSmithKline Recent Development Table 63. Bayer AG Company Information Table 64. Bayer AG Business Overview Table 65. Bayer AG Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Bayer AG Ophthalmic Corticosteroid Product Portfolio Table 67. Bayer AG Recent Development Table 68. Sun Pharmaceutical Company Information Table 69. Sun Pharmaceutical Business Overview Table 70. Sun Pharmaceutical Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sun Pharmaceutical Ophthalmic Corticosteroid Product Portfolio Table 72. Sun Pharmaceutical Recent Development Table 73. Regeneron Pharmaceuticals Company Information Table 74. Regeneron Pharmaceuticals Business Overview Table 75. Regeneron Pharmaceuticals Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Regeneron Pharmaceuticals Ophthalmic Corticosteroid Product Portfolio Table 77. Regeneron Pharmaceuticals Recent Development Table 78. Orchidia Company Information Table 79. Orchidia Business Overview Table 80. Orchidia Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Orchidia Ophthalmic Corticosteroid Product Portfolio Table 82. Orchidia Recent Development Table 83. Innovative Pharmaceuticals Company Information Table 84. Innovative Pharmaceuticals Business Overview Table 85. Innovative Pharmaceuticals Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Innovative Pharmaceuticals Ophthalmic Corticosteroid Product Portfolio Table 87. Innovative Pharmaceuticals Recent Development Table 88. General Pharmaceuticals Company Information Table 89. General Pharmaceuticals Business Overview Table 90. General Pharmaceuticals Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. General Pharmaceuticals Ophthalmic Corticosteroid Product Portfolio Table 92. General Pharmaceuticals Recent Development Table 93. Genentech Company Information Table 94. Genentech Business Overview Table 95. Genentech Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Genentech Ophthalmic Corticosteroid Product Portfolio Table 97. Genentech Recent Development Table 98. Bausch Health Company Information Table 99. Bausch Health Business Overview Table 100. Bausch Health Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Bausch Health Ophthalmic Corticosteroid Product Portfolio Table 102. Bausch Health Recent Development Table 103. Bausch and Lomb Company Information Table 104. Bausch and Lomb Business Overview Table 105. Bausch and Lomb Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bausch and Lomb Ophthalmic Corticosteroid Product Portfolio Table 107. Bausch and Lomb Recent Development Table 108. Allergan Company Information Table 109. Allergan Business Overview Table 110. Allergan Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Allergan Ophthalmic Corticosteroid Product Portfolio Table 112. Allergan Recent Development Table 113. Alimera Sciences Company Information Table 114. Alimera Sciences Business Overview Table 115. Alimera Sciences Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Alimera Sciences Ophthalmic Corticosteroid Product Portfolio Table 117. Alimera Sciences Recent Development Table 118. Ajanta Pharma Company Information Table 119. Ajanta Pharma Business Overview Table 120. Ajanta Pharma Ophthalmic Corticosteroid Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Ajanta Pharma Ophthalmic Corticosteroid Product Portfolio Table 122. Ajanta Pharma Recent Development Table 123. North America Ophthalmic Corticosteroid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Ophthalmic Corticosteroid Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Ophthalmic Corticosteroid Market Share by Country (2021-2026) Table 126. North America Ophthalmic Corticosteroid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Ophthalmic Corticosteroid Market Share Forecast by Country (2027-2032) Table 128. Europe Ophthalmic Corticosteroid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Ophthalmic Corticosteroid Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Ophthalmic Corticosteroid Market Share by Country (2021-2026) Table 131. Europe Ophthalmic Corticosteroid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Ophthalmic Corticosteroid Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Ophthalmic Corticosteroid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Ophthalmic Corticosteroid Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Ophthalmic Corticosteroid Market Share by Country (2021-2026) Table 136. Asia-Pacific Ophthalmic Corticosteroid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Ophthalmic Corticosteroid Market Share Forecast by Country (2027-2032) Table 138. Latin America Ophthalmic Corticosteroid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Ophthalmic Corticosteroid Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Ophthalmic Corticosteroid Market Share by Country (2021-2026) Table 141. Latin America Ophthalmic Corticosteroid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Ophthalmic Corticosteroid Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Ophthalmic Corticosteroid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Ophthalmic Corticosteroid Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Ophthalmic Corticosteroid Market Share by Country (2021-2026) Table 146. Middle East & Africa Ophthalmic Corticosteroid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Ophthalmic Corticosteroid Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Ophthalmic Corticosteroid Product Image Figure 3. Global Ophthalmic Corticosteroid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 5. Global Ophthalmic Corticosteroid Market Share by Region: 2025 VS 2032 Figure 6. Global Ophthalmic Corticosteroid Market Share by Region (2021-2032) Figure 7. North America Ophthalmic Corticosteroid Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Ophthalmic Corticosteroid Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Ophthalmic Corticosteroid Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Ophthalmic Corticosteroid Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Ophthalmic Corticosteroid Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Dexamethasone Image Figure 13. Global Dexamethasone Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Difluprednate Image Figure 15. Global Difluprednate Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Fluorometholone Image Figure 17. Global Fluorometholone Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Loteprednol Image Figure 19. Global Loteprednol Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Ophthalmic Corticosteroid Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Ophthalmic Corticosteroid Market Share by Type 2025 VS 2032 Figure 24. North America Ophthalmic Corticosteroid Market Size Share by Type (2021-2032) Figure 25. Europe Ophthalmic Corticosteroid Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Ophthalmic Corticosteroid Market Size Share by Type (2021-2032) Figure 27. Latin America Ophthalmic Corticosteroid Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Ophthalmic Corticosteroid Market Size Share by Type (2021-2032) Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Research Institute Image Figure 32. Global Research Institute Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Online Pharmacies Image Figure 34. Global Online Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Retail Pharmacies Image Figure 36. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Ophthalmic Corticosteroid Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Ophthalmic Corticosteroid Market Share by Application 2025 VS 2032 Figure 41. North America Ophthalmic Corticosteroid Market Size Share by Application (2021-2032) Figure 42. Europe Ophthalmic Corticosteroid Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Ophthalmic Corticosteroid Market Size Share by Application (2021-2032) Figure 44. Latin America Ophthalmic Corticosteroid Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Ophthalmic Corticosteroid Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Ophthalmic Corticosteroid Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Ophthalmic Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Ophthalmic Corticosteroid Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Ophthalmic Corticosteroid Market Share by Country (2021-2032) Figure 51. Europe Ophthalmic Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Ophthalmic Corticosteroid Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Ophthalmic Corticosteroid Market Share by Country (2021-2032) Figure 54. Asia-Pacific Ophthalmic Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Ophthalmic Corticosteroid Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Ophthalmic Corticosteroid Market Share by Country (2021-2032) Figure 57. Latin America Ophthalmic Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Ophthalmic Corticosteroid Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Ophthalmic Corticosteroid Market Share by Country (2021-2032) Figure 60. Middle East & Africa Ophthalmic Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Ophthalmic Corticosteroid Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Ophthalmic Corticosteroid Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Dexamethasone
  • Difluprednate
  • Fluorometholone
  • Loteprednol
  • Others
Applications
  • Hospital Pharmacies
  • Research Institute
  • Online Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Novartis AG
  • Pfizer
  • GlaxoSmithKline
  • Bayer AG
  • Sun Pharmaceutical
  • Regeneron Pharmaceuticals
  • Orchidia
  • Innovative Pharmaceuticals
  • General Pharmaceuticals
  • Genentech
  • Bausch Health
  • Bausch and Lomb
  • Allergan
  • Alimera Sciences
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Ophthalmic Corticosteroid Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Ophthalmic Corticosteroid Market Size by Region (2021-2032)
  5. 1.4.1 Global Ophthalmic Corticosteroid Market Size by Region (2021-2026)
  6. 1.4.2 Global Ophthalmic Corticosteroid Market Size by Region (2027-2032)
  7. 1.5 Key Regions Ophthalmic Corticosteroid Market Size (2021-2032)
  8. 1.5.1 North America Ophthalmic Corticosteroid Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Ophthalmic Corticosteroid Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Ophthalmic Corticosteroid Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Ophthalmic Corticosteroid Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Ophthalmic Corticosteroid Market Size Growth Rate (2021-2032)
2 Ophthalmic Corticosteroid Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Dexamethasone
  3. 2.1.2 Difluprednate
  4. 2.1.3 Fluorometholone
  5. 2.1.4 Loteprednol
  6. 2.1.5 Others
  7. 2.2 Global Ophthalmic Corticosteroid Market Size by Type
  8. 2.2.1 Global Ophthalmic Corticosteroid Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Ophthalmic Corticosteroid Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Ophthalmic Corticosteroid Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Ophthalmic Corticosteroid Market Size by Regions
  12. 2.3.1 North America Ophthalmic Corticosteroid Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Ophthalmic Corticosteroid Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Ophthalmic Corticosteroid Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Ophthalmic Corticosteroid Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Ophthalmic Corticosteroid Market Size Breakdown by Type (2021-2026)
3 Ophthalmic Corticosteroid Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacies
  3. 3.1.2 Research Institute
  4. 3.1.3 Online Pharmacies
  5. 3.1.4 Retail Pharmacies
  6. 3.1.5 Others
  7. 3.2 Global Ophthalmic Corticosteroid Market Size by Application
  8. 3.2.1 Global Ophthalmic Corticosteroid Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Ophthalmic Corticosteroid Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Ophthalmic Corticosteroid Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Ophthalmic Corticosteroid Market Size by Regions
  12. 3.3.1 North America Ophthalmic Corticosteroid Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Ophthalmic Corticosteroid Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Ophthalmic Corticosteroid Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Ophthalmic Corticosteroid Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Ophthalmic Corticosteroid Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Ophthalmic Corticosteroid Industry Trends
  2. 4.2 Ophthalmic Corticosteroid Industry Drivers
  3. 4.3 Ophthalmic Corticosteroid Industry Opportunities and Challenges
  4. 4.4 Ophthalmic Corticosteroid Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Ophthalmic Corticosteroid Revenue (2021-2026)
  2. 5.2 Global Ophthalmic Corticosteroid Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Ophthalmic Corticosteroid Key Company Headquarters & Area Served
  4. 5.4 Global Ophthalmic Corticosteroid Company, Product Type & Application
  5. 5.5 Global Ophthalmic Corticosteroid Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Ophthalmic Corticosteroid Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Ophthalmic Corticosteroid Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Ophthalmic Corticosteroid Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Ophthalmic Corticosteroid Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Ophthalmic Corticosteroid Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Ophthalmic Corticosteroid Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Bayer AG
  20. 6.4.1 Bayer AG Company Information
  21. 6.4.2 Bayer AG Business Overview
  22. 6.4.3 Bayer AG Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Bayer AG Ophthalmic Corticosteroid Product Portfolio
  24. 6.4.5 Bayer AG Recent Developments
  25. 6.5 Sun Pharmaceutical
  26. 6.5.1 Sun Pharmaceutical Company Information
  27. 6.5.2 Sun Pharmaceutical Business Overview
  28. 6.5.3 Sun Pharmaceutical Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sun Pharmaceutical Ophthalmic Corticosteroid Product Portfolio
  30. 6.5.5 Sun Pharmaceutical Recent Developments
  31. 6.6 Regeneron Pharmaceuticals
  32. 6.6.1 Regeneron Pharmaceuticals Company Information
  33. 6.6.2 Regeneron Pharmaceuticals Business Overview
  34. 6.6.3 Regeneron Pharmaceuticals Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Regeneron Pharmaceuticals Ophthalmic Corticosteroid Product Portfolio
  36. 6.6.5 Regeneron Pharmaceuticals Recent Developments
  37. 6.7 Orchidia
  38. 6.7.1 Orchidia Company Information
  39. 6.7.2 Orchidia Business Overview
  40. 6.7.3 Orchidia Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Orchidia Ophthalmic Corticosteroid Product Portfolio
  42. 6.7.5 Orchidia Recent Developments
  43. 6.8 Innovative Pharmaceuticals
  44. 6.8.1 Innovative Pharmaceuticals Company Information
  45. 6.8.2 Innovative Pharmaceuticals Business Overview
  46. 6.8.3 Innovative Pharmaceuticals Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Innovative Pharmaceuticals Ophthalmic Corticosteroid Product Portfolio
  48. 6.8.5 Innovative Pharmaceuticals Recent Developments
  49. 6.9 General Pharmaceuticals
  50. 6.9.1 General Pharmaceuticals Company Information
  51. 6.9.2 General Pharmaceuticals Business Overview
  52. 6.9.3 General Pharmaceuticals Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 General Pharmaceuticals Ophthalmic Corticosteroid Product Portfolio
  54. 6.9.5 General Pharmaceuticals Recent Developments
  55. 6.10 Genentech
  56. 6.10.1 Genentech Company Information
  57. 6.10.2 Genentech Business Overview
  58. 6.10.3 Genentech Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Genentech Ophthalmic Corticosteroid Product Portfolio
  60. 6.10.5 Genentech Recent Developments
  61. 6.11 Bausch Health
  62. 6.11.1 Bausch Health Company Information
  63. 6.11.2 Bausch Health Business Overview
  64. 6.11.3 Bausch Health Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Bausch Health Ophthalmic Corticosteroid Product Portfolio
  66. 6.11.5 Bausch Health Recent Developments
  67. 6.12 Bausch and Lomb
  68. 6.12.1 Bausch and Lomb Company Information
  69. 6.12.2 Bausch and Lomb Business Overview
  70. 6.12.3 Bausch and Lomb Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bausch and Lomb Ophthalmic Corticosteroid Product Portfolio
  72. 6.12.5 Bausch and Lomb Recent Developments
  73. 6.13 Allergan
  74. 6.13.1 Allergan Company Information
  75. 6.13.2 Allergan Business Overview
  76. 6.13.3 Allergan Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Allergan Ophthalmic Corticosteroid Product Portfolio
  78. 6.13.5 Allergan Recent Developments
  79. 6.14 Alimera Sciences
  80. 6.14.1 Alimera Sciences Company Information
  81. 6.14.2 Alimera Sciences Business Overview
  82. 6.14.3 Alimera Sciences Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Alimera Sciences Ophthalmic Corticosteroid Product Portfolio
  84. 6.14.5 Alimera Sciences Recent Developments
  85. 6.15 Ajanta Pharma
  86. 6.15.1 Ajanta Pharma Company Information
  87. 6.15.2 Ajanta Pharma Business Overview
  88. 6.15.3 Ajanta Pharma Ophthalmic Corticosteroid Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Ajanta Pharma Ophthalmic Corticosteroid Product Portfolio
  90. 6.15.5 Ajanta Pharma Recent Developments
7 North America
  1. 7.1 North America Ophthalmic Corticosteroid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Ophthalmic Corticosteroid Market Size by Country (2021-2026)
  3. 7.3 North America Ophthalmic Corticosteroid Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Ophthalmic Corticosteroid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Ophthalmic Corticosteroid Market Size by Country (2021-2026)
  3. 8.3 Europe Ophthalmic Corticosteroid Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Ophthalmic Corticosteroid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Ophthalmic Corticosteroid Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Ophthalmic Corticosteroid Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Ophthalmic Corticosteroid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Ophthalmic Corticosteroid Market Size by Country (2021-2026)
  3. 10.3 South America Ophthalmic Corticosteroid Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Ophthalmic Corticosteroid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Ophthalmic Corticosteroid Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Ophthalmic Corticosteroid Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst